| |
|
|
|
|
|
|
|||
|
Blood, 1 June 2004, Vol. 103, No. 11, pp. 4093-4101. Prepublished online as a Blood First Edition Paper on February 19, 2004; DOI 10.1182/blood-2003-06-2165.
Submitted June 30, 2003
Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA * Corresponding author; email: reddy{at}temple.edu.
We report here that Jak3 is a primary response gene for IL-6 in macrophage differentiation and ectopic overexpression of JAK3 accelerates monocytic differentiation of murine M1 myeloid leukemia cells as well as normal mouse bone marrow cells stimulated with cytokines. Furthermore, we show that incubation of normal mouse bone marrow cells with a JAK3-specific inhibitor results in a profound inhibition of myeloid colony formation in response to GM-CSF or the combination of SCF, IL-3, and IL-6. In addition, mutagenesis of the Jak3 promoter has revealed that Sp1 binding sites within a -67 to -85 element and a STAT binding site at position -44 to -53 are critical for activation of Jak3 transcription in M1 cells stimulated with IL-6. EMSA analysis has demonstrated that Sp1 can bind to the -67 to -85 element and STAT3 can bind to the -44 to -53 STAT site in IL-6-stimulated M1 cells. Additionally, ectopic overexpression of STAT3 enhanced Jak3 promoter activity in M1 cells. This mechanism of activation of the murine Jak3 promoter in myeloid cells is distinct from a recently reported method of activation of the human Jak3 promoter in activated T cells.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2004 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||